1383P Efficacy of capmatinib compared to standard of care for German patients with locally advanced or metastatic NSCLC harboring METex14 mutations: Results from the RECAP study von Kron, A., Scheffler, M., Wiesweg, M., Hummel, H-D., Kulhavy, J., Gattenlöhner, S., Kollmeier, J., Schubart, C., Gross, T., Demes, M., Keymel, S., Joosten, M., Merkelbach-Bruse, S., Wölwer, C., Oeser, K., Zehaczek, M., Jeratsch, U., Wolf, J.

Volltext